Banque Pictet & Cie’s ChemoCentryx, Inc. CCXI Stock Holding History

Banque Pictet & Cie’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-54,178	Closed	-$737K	–	371
2018 Q1	$737K	Hold	54,178	–	–	0.02%	258
2017 Q4	$322K	Hold	54,178	–	–	0.01%	312
2017 Q3	$402K	Hold	54,178	–	–	0.01%	308
2017 Q2	$507K	Hold	54,178	–	–	0.01%	300
2017 Q1	$394K	Sell	54,178 -21,028	-28%	-$151K	0.01%	293
2016 Q4	$557K	Hold	75,206	–	–	0.01%	269
2016 Q3	$454K	Hold	75,206	–	–	0.01%	268
2016 Q2	$338K	Buy	75,206 +21,028	+39%	+$78.9K	0.01%	282
2016 Q1	$135K	Hold	54,178	–	–	﹤0.01%	317
2015 Q4	$439K	Hold	54,178	–	–	0.01%	255
2015 Q3	$328K	Sell	54,178 -17,782	-25%	-$129K	0.01%	293
2015 Q2	$592K	Hold	71,960	–	–	0.05%	192
2015 Q1	$543K	Hold	71,960	–	–	0.01%	311
2014 Q4	$491K	Hold	71,960	–	–	0.01%	312
2014 Q3	$324K	Hold	71,960	–	–	0.01%	358
2014 Q2	$421K	Hold	71,960	–	–	0.01%	294
2014 Q1	$477K	Buy	71,960 +21,028	+41%	+$146K	0.01%	271
2013 Q4	$295K	Buy	+50,932	New	+$263K	0.01%	291

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Banque Pictet & Cie's CCXI Position: Q2 2018 in Review

Banque Pictet & Cie sold out of ChemoCentryx, Inc. (CCXI) in Q2 2018, closing a stake of 54,178 shares — an estimated $737K sold.

Banque Pictet & Cie first reported a position in CCXI in Q4 2013 and held it in 18 quarters. The position peaked at $737K in Q1 2018. 115 funds tracked by Wall St. Rank hold CCXI as of Q2 2018.

Banque Pictet & Cie reported no remaining ChemoCentryx, Inc. position as of Q2 2018 after selling out during the quarter.
Banque Pictet & Cie sold 54,178 ChemoCentryx, Inc. shares in Q2 2018, an estimated $737K.
Banque Pictet & Cie first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 18 quarters.
Banque Pictet & Cie's ChemoCentryx, Inc. position peaked at $737K in Q1 2018.
115 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2018.

Based on Banque Pictet & Cie's 13F filing for Q2 2018, filed 9 Aug 2018.